In two randomized clinical trials that evaluate pain control after common and bunionectomy, Journavx has shown statistically significant reductions in acute surgical pain over a 48…
The Food and Drug Administration (FDA) approved the Journavx ™ (Suzetrigine) to treat measure to severe acid pain in adults. The active ingredient in Journavx is…
